Literature DB >> 9455945

Congenital cholesteatoma of the middle ear: occurrence of an "open" lesion.

K C Soderberg1, J L Dornhoffer.   

Abstract

OBJECTIVE: This study aimed to investigate the occurrence of an "open" form of congenital cholesteatoma to facilitate better understanding of the different histopathologic forms and their differing clinical presentations. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Ten patients diagnosed with congenital cholesteatoma, that is, a white "pearl" behind an intact tympanic membrane with no history of trauma, ear surgery, perforation, or otorrhea. MAIN OUTCOME MEASURES: Audiometry, high-resolution computed tomography scan of the temporal bones and intraoperative findings.
RESULTS: Two of 10 patients had lesions located in the anterosuperior quadrant of the mesotympanum. Four patients had lesions involving the entire middle ear cleft. Four patients had lesions in the posterosuperior quadrant. Seven of the patients were found to have a typical "closed" cyst, whereas the remaining three patients showed an open cholesteatoma matrix.
CONCLUSIONS: Apparently, there are two types of congenital middle ear cholesteatoma: a closed keratotic cyst and an open matrix. Patients with open cholesteatomas may have a clinical presentation that is uniquely different from the classical description of congenital cholesteatoma.

Entities:  

Mesh:

Year:  1998        PMID: 9455945

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  2 in total

1.  Stage progression of congenital cholesteatoma in children.

Authors:  Young Ho Kim; Jae Chul Yoo; Jun Ho Lee; Seung-Ha Oh; Sun O Chang; Ja-Won Koo; Chong Sun Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-06       Impact factor: 2.503

2.  Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis.

Authors:  Nelson Gilberto; Sara Custódio; Tiago Colaço; Ricardo Santos; Pedro Sousa; Pedro Escada
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-18       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.